Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date

Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date

Renaud Felten,1–3 Florence Scher,4 Flora Sagez,1,2 François Chasset,5 Laurent Arnaud1,2,61Rheumatology Department, University Hospital of Strasbourg, Université de Strasbourg, Strasbourg, F-67000, France; 2National Reference Centre for Rare Systemic and Autoimmune Dis...

Full description

Bibliographic Details
Main Authors: Felten R, Scher F, Sagez F, Chasset F, Arnaud L
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Drug Design, Development and Therapy
Subjects:
Systemic Lupus Erythematosus
Interferon Type I
Interferon-alpha
Anifrolumab
"Receptors
Interferon
Online Access:https://www.dovepress.com/spotlight-on-anifrolumab-and-its-potential-for-the-treatment-of-modera-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/spotlight-on-anifrolumab-and-its-potential-for-the-treatment-of-modera-peer-reviewed-article-DDDT

Similar Items